Teva plans to keep its OTC assets for now

9 January 2019 - Deborah Wilkes


Generics giant Teva Pharmaceutical intends to "leverage and grow" its OTC interests as a "core asset".

Click tags below for more information on topics:


Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: